BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 14720026)

  • 1. Lung cancer screening: will the controversy extend to its cost-effectiveness?
    Klittich WS; Caro JJ
    Am J Respir Med; 2002; 1(6):393-401. PubMed ID: 14720026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of lung cancer screening in Japan.
    Okamoto N
    Cancer; 2000 Dec; 89(11 Suppl):2489-93. PubMed ID: 11147633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening results in the National Cancer Institute New York study.
    Melamed MR
    Cancer; 2000 Dec; 89(11 Suppl):2356-62. PubMed ID: 11147612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a proposed feasibility study on the detection of early lung carcinoma in Germany.
    Nakhosteen JA
    Cancer; 2000 Dec; 89(11 Suppl):2494-6. PubMed ID: 11147634
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of Lung Cancer Screening in Canada.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    JAMA Oncol; 2015 Sep; 1(6):807-13. PubMed ID: 26226181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research Progress on Lung Cancer Screening].
    Guan Y; Ren M; Guo D; He Y
    Zhongguo Fei Ai Za Zhi; 2020 Nov; 23(11):954-960. PubMed ID: 32819054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.
    Raymakers AJN; Mayo J; Lam S; FitzGerald JM; Whitehurst DGT; Lynd LD
    Appl Health Econ Health Policy; 2016 Aug; 14(4):409-418. PubMed ID: 26873091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening and management.
    Jones GS; Baldwin DR
    Minerva Med; 2015 Dec; 106(6):339-54. PubMed ID: 26605556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada.
    Ten Haaf K; Tammemägi MC; Bondy SJ; van der Aalst CM; Gu S; McGregor SE; Nicholas G; de Koning HJ; Paszat LF
    PLoS Med; 2017 Feb; 14(2):e1002225. PubMed ID: 28170394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating the Cost-Effectiveness of Lung Cancer Screening with Low-Dose Computed Tomography for High-Risk Smokers in Australia.
    Wade S; Weber M; Caruana M; Kang YJ; Marshall H; Manser R; Vinod S; Rankin N; Fong K; Canfell K
    J Thorac Oncol; 2018 Aug; 13(8):1094-1105. PubMed ID: 29689434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison of two types of mass screening for lung cancer in terms of cost-effectiveness: indirect chest X-ray vs LSCT].
    Iinuma T; Tateno Y; Matsumoto T
    Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Sep; 54(10):943-9. PubMed ID: 7971185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Protocols for lung cancer screening: Limitations, and consequences].
    Clément-Duchêne C; Guillemin F; Paris C; Régent D; Martinet Y
    Rev Mal Respir; 2010 Apr; 27(4):314-28. PubMed ID: 20403542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for lung cancer with low-dose computed tomography: a systematic literature review.
    Puggina A; Broumas A; Ricciardi W; Boccia S
    Eur J Public Health; 2016 Feb; 26(1):168-75. PubMed ID: 26370440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case finding in bronchial carcinoma: cost-effectiveness].
    Junod AF
    Schweiz Med Wochenschr; 1987 Sep; 117(39):1464-5. PubMed ID: 3118457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trade-off between benefits, harms and economic efficiency of low-dose CT lung cancer screening: a microsimulation analysis of nodule management strategies in a population-based setting.
    Treskova M; Aumann I; Golpon H; Vogel-Claussen J; Welte T; Kuhlmann A
    BMC Med; 2017 Aug; 15(1):162. PubMed ID: 28838313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
    Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
    Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer screening: examining the issues.
    Mazzone P
    Cleve Clin J Med; 2012 May; 79 Electronic Suppl 1():eS1-6. PubMed ID: 22614958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for lung cancer: a review.
    Manser R
    Curr Opin Pulm Med; 2004 Jul; 10(4):266-71. PubMed ID: 15220750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Screening for early detection of lung cancer: conflict between clinical and public health viewpoints].
    Döbrossy L; Kovács A; Budai A; Cornides A
    Orv Hetil; 2007 Aug; 148(34):1587-90. PubMed ID: 17702686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.